KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Net Cash Flow (2016 - 2025)

Medpace Holdings' Net Cash Flow history spans 11 years, with the latest figure at $210.9 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 1355.04% year-over-year to $210.9 million; the TTM value through Dec 2025 reached -$178.3 million, down 141.81%, while the annual FY2025 figure was -$178.3 million, 141.81% down from the prior year.
  • Net Cash Flow reached $210.9 million in Q4 2025 per MEDP's latest filing, down from $239.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $239.0 million in Q3 2025 to a low of -$398.1 million in Q2 2025.
  • Average Net Cash Flow over 5 years is $11.3 million, with a median of $37.2 million recorded in 2023.
  • Peak YoY movement for Net Cash Flow: tumbled 764.14% in 2022, then skyrocketed 4199.56% in 2023.
  • A 5-year view of Net Cash Flow shows it stood at $64.2 million in 2021, then crashed by 105.7% to -$3.7 million in 2022, then surged by 4199.56% to $149.9 million in 2023, then tumbled by 90.33% to $14.5 million in 2024, then soared by 1355.04% to $210.9 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Net Cash Flow are $210.9 million (Q4 2025), $239.0 million (Q3 2025), and -$398.1 million (Q2 2025).